BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21152453)

  • 1. Biomarkers for multiple sclerosis.
    Villoslada P
    Drug News Perspect; 2010 Nov; 23(9):585-95. PubMed ID: 21152453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis.
    Villoslada P; Baranzini S
    J Neuroimmunol; 2012 Jul; 248(1-2):58-65. PubMed ID: 22281286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating the tools for an individualized prognosis in multiple sclerosis.
    Fernández O
    J Neurol Sci; 2013 Aug; 331(1-2):10-3. PubMed ID: 23692966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in multiple sclerosis.
    Bergamaschi R
    Int Rev Neurobiol; 2007; 79():423-47. PubMed ID: 17531853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biomarkers in multiple sclerosis].
    Fernández Ó; Arroyo-González R; Rodríguez-Antigüedad A; García-Merino JA; Comabella M; Villar LM; Izquierdo G; Tintoré M; Oreja-Guevara C; Álvarez-Cermeño JC; Meca-Lallana JE; Prieto JM; Ramió-Torrentà L; Martínez-Yélamos S; Montalban X
    Rev Neurol; 2013 Apr; 56(7):375-90. PubMed ID: 23520007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.
    Ghezzi A; Bergamaschi R; Martinelli V; Trojano M; Tola MR; Merelli E; Mancardi L; Gallo P; Filippi M; Zaffaroni M; Comi G;
    J Neurol; 2004 Jan; 251(1):47-52. PubMed ID: 14999489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
    Sepulcre J; Murie-Fernandez M; Salinas-Alaman A; García-Layana A; Bejarano B; Villoslada P
    Neurology; 2007 May; 68(18):1488-94. PubMed ID: 17470751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging biomarkers in multiple sclerosis.
    Filippi M; Agosta F
    J Magn Reson Imaging; 2010 Apr; 31(4):770-88. PubMed ID: 20373420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of disease activity in multiple sclerosis.
    Graber JJ; Dhib-Jalbut S
    J Neurol Sci; 2011 Jun; 305(1-2):1-10. PubMed ID: 21463872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward biomarkers in multiple sclerosis: new advances.
    Lolli F; Rovero P; Chelli M; Papini AM
    Expert Rev Neurother; 2006 May; 6(5):781-94. PubMed ID: 16734525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis.
    Awad A; Hemmer B; Hartung HP; Kieseier B; Bennett JL; Stuve O
    J Neuroimmunol; 2010 Feb; 219(1-2):1-7. PubMed ID: 19782408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The combined use of instrumental and laboratory examinations in multiple sclerosis: is the diagnostic facilitation real?].
    Paolino E; Granieri E; Tola MR; Govoni V; Casetta I; Monetti VC; Carreras M
    Riv Neurol; 1990; 60(2):73-81. PubMed ID: 2247751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Devic's neuromyelitis optica. Presentation of 2 new cases and review of the bibliography].
    Carod Artal FJ; Brenner C; Melo M; del Negro MC; Pereira R
    Neurologia; 2000; 15(7):307-12. PubMed ID: 11075580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late onset multiple sclerosis].
    Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
    Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: disease biomarkers as indicated by pathophysiology.
    Berger T; Reindl M
    J Neurol Sci; 2007 Aug; 259(1-2):21-6. PubMed ID: 17367811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.